Cisplatin/Carboplatin Shortages Persist Across Majority of N

Shortages of cisplatin and carboplatin have continued at the majority of National Cancer Center Network (NCCN) institutions, according to data from a follow-up survey conducted by NCCN.

Related Keywords

White House , District Of Columbia , United States , Alyssa Schatz , Robertw Carlson , Centers For Medicaid , National Cancer Institute , National Cancer Center Network , National Comprehensive Cancer Network , Comprehensive Cancer , Nccn , Carboplatin , Cisplatin , Chemotherapy Shortage ,